Gerresheimer Glas GmbH has signed an agreement to acquire Blitz LuxCo Sarl, the holding company of Bormioli Pharma Group, from the private equity firm Triton. This strategic acquisition significantly strengthens Gerresheimer's footprint in Southern Europe and expands its portfolio of moulded glass and plastic packaging solutions. By integrating Bormioli Pharma's nine European production sites, Gerresheimer accelerates its transformation into a holistic system and solution provider, offering complete "bottle-and-closure" combinations. The transaction is expected to be accretive to earnings per share (EPS) by more than 10% in the first year and generate meaningful commercial and operational synergies.

BLITZ LUXCO, which reported an EBITDA margin of LOGIN in 2023, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a level LOGIN the 10.5x average currently observed in the Industry & Manufacturing sector.

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.